Boehringer Ingelheim appoints César Nieto to lead its expansion ambitions in Sub-Saharan Africa

SOUTH AFRICA – Boehringer Ingelheim, one of the world’s largest pharmaceutical companies, has announced César Nieto as the General Manager & Head of Human Pharma, Southern Africa Cluster (South Africa and Sub-Saharan Africa Markets) based out of Johannesburg, South Africa. 

On Boeheringer Ingelheim part, this is a strategic move to strengthen its presence in Southern Africa.

César Nieto was the general manager and head of Human Pharma for the region before the new appointment. 

As part of his responsibilities, Nieto will manage the Southern Africa region which includes South Africa and sub-Saharan African countries.

Nieto is a qualified physician and previously held senior leadership positions with the company in North and Central America, Caribbean, United Arab Emirates, and the company’s headquarters in Germany.

Mohammed Tawil, regional managing director and head of Human Pharma for Boehringer Ingelheim’s India, Middle East, Turkey and Africa (Imeta) region, said, “Nieto has a proven track record of success in driving growth for Boehringer Ingelheim.His diverse experience will be key to our ability to drive sustainable growth.”

Tawil noted that Boehringer was confident that he would help fulfil the purpose of transforming lives for generations by bringing innovative healthcare solutions to address areas of unmet medical needs in the region.

Acknowledging the appointment, Nieto said, “Through strong partnerships with our stakeholders and Boehringer Ingelheim team, I’m confident that we can positively impact the patients and communities and contribute to healthcare innovation.”

Nieto has M.D. from the Universidad Anáhuac and Masters in Hopital Administration from the Universidad La Salle in Mexico. 

Nieto was previously the regional cardiovascular therapeutic area lead at Boehringer Ingelheim Imeta, where he played a key role in the transformation of the company’s cardiovascular and stroke portfolio.

Additionally, his strategy in this role served as a blueprint for other regions such as Brazil, Mexico, UK and Ireland, and led to an increase in profitability in Imeta.

Boehringer Ingelheim has been in the South African market since 1962 and later grew the network into Namibia and Botswana. 

Recently, the regional headquarters has extended its representation to the sub-Saharan African region.

As of 2018, Boehringer Ingelheim is one of the world’s largest pharmaceutical companies, and the largest private one.

Headquartered in Germany, it operates globally with 146 affiliates and more than 47,700 employees. 

The company’s key areas of interest are: respiratory diseases, metabolism, immunology, oncology and diseases of the central nervous system.

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.